These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21472711)

  • 1. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
    Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
    Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Tang J; Sharif O; Pai C; Silverman AL
    Dig Dis Sci; 2010 Jun; 55(6):1696-703. PubMed ID: 19705280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
    Ananthakrishnan AN; Cagan A; Cai T; Gainer VS; Shaw SY; Churchill S; Karlson EW; Murphy SN; Liao KP; Kohane I
    Clin Gastroenterol Hepatol; 2016 Jul; 14(7):973-9. PubMed ID: 26905907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.
    Terdiman JP; Steinbuch M; Blumentals WA; Ullman TA; Rubin DT
    Inflamm Bowel Dis; 2007 Apr; 13(4):367-71. PubMed ID: 17206695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
    Burr NE; Hull MA; Subramanian V
    World J Gastroenterol; 2016 Apr; 22(13):3679-86. PubMed ID: 27053860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.
    Shadman M; Newcomb PA; Hampton JM; Wernli KJ; Trentham-Dietz A
    World J Gastroenterol; 2009 May; 15(19):2336-9. PubMed ID: 19452574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.
    Vinogradova Y; Hippisley-Cox J; Coupland C; Logan RF
    Gastroenterology; 2007 Aug; 133(2):393-402. PubMed ID: 17681160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
    Chan EP; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of colorectal cancer in inflammatory bowel disease.
    Bansal P; Sonnenberg A
    Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study.
    Baars JE; Looman CW; Steyerberg EW; Beukers R; Tan AC; Weusten BL; Kuipers EJ; van der Woude CJ
    Am J Gastroenterol; 2011 Feb; 106(2):319-28. PubMed ID: 21045815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
    Cheung KS; Chen L; Chan EW; Seto WK; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2020 May; 51(9):899-908. PubMed ID: 32201976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.
    Hachem C; Morgan R; Johnson M; Kuebeler M; El-Serag H
    Am J Gastroenterol; 2009 May; 104(5):1241-8. PubMed ID: 19352344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.